BioMark Diagnostics Inc.
BMKDF
$0.33
-$0.02-5.90%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -16.23% | -2.28% | -22.91% | 40.39% | 11.90% |
| Total Depreciation and Amortization | -13.50% | -54.08% | 278.23% | -1.88% | 0.95% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 32.73% | -62.07% | 35.51% | -77.21% | -43.71% |
| Change in Net Operating Assets | -833.96% | 105.10% | -615.88% | -76.14% | 1,295.87% |
| Cash from Operations | -69.39% | 34.42% | -132.23% | -41.54% | 59.13% |
| Capital Expenditure | -350.00% | -100.00% | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 156.48% | -- | -- | -- | -- |
| Cash from Investing | 155.95% | -194,471.43% | -- | -- | 100.00% |
| Total Debt Issued | 0.00% | 0.00% | -19.04% | 23.52% | 0.00% |
| Total Debt Repaid | 21.96% | -8.62% | -42.62% | -4.81% | 25.10% |
| Issuance of Common Stock | -- | -- | 1,047.57% | 400.78% | -86.36% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 41.47% | -103.64% | 1,038.40% | 895.43% | -92.22% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 122.55% | -198.39% | 4,231.17% | 149.23% | -598.21% |